Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Y. H. | - |
dc.contributor.author | Woo, J-H | - |
dc.contributor.author | Choi, S. J. | - |
dc.contributor.author | Ji, J. D. | - |
dc.contributor.author | Song, G. G. | - |
dc.date.accessioned | 2021-09-08T03:25:13Z | - |
dc.date.available | 2021-09-08T03:25:13Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2010-05 | - |
dc.identifier.issn | 0961-2033 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/116507 | - |
dc.description.abstract | The aim of this study was to assess the efficacies and toxicities of immunosuppressive treatments for lupus nephritis (LN) versus cyclophosphamide (CYC). A meta-analysis was performed to determine treatment efficacy and toxicity outcomes between mycophenolate mofetil (MMF) and CYC induction therapies, between MMF and azathioprine (AZA) as maintenance therapies, and between low-dose intravenous (IV) CYC and high-dose IV CYC therapy. Ten randomized controlled trials (RCTs) were included in the meta-analysis. In terms of induction therapies, MMF did not increase complete remission or partial remission rates as compared with CYC. However, the relative risks (RRs) of amenorrhea and leukopenia tended to be lower in the MMF group than in the CYC group. Meta-analysis of MMF versus AZA as a maintenance therapy showed no difference between the two groups in terms of response rates or the risk of developing end-stage renal disease. Low-dose IV CYC therapy had lower relapse rates than high-dose IV CYC therapy (RR 0.465, 95% confidence interval [CI] 0.261-0.830, p-value 0.010), and was associated with a lower infection risk (RR 0.688, 95% CI 0.523-0.905, p-value 0.008). In conclusion, MMF was found to be as effective as CYC and tended to have a better safety profile as an induction therapy for LN than CYC. Lupus (2010) 19, 703-710. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject | MYCOPHENOLATE-MOFETIL | - |
dc.subject | INTRAVENOUS CYCLOPHOSPHAMIDE | - |
dc.subject | IMMUNOSUPPRESSIVE THERAPY | - |
dc.subject | PULSE CYCLOPHOSPHAMIDE | - |
dc.subject | LONG-TERM | - |
dc.subject | AZATHIOPRINE | - |
dc.subject | ERYTHEMATOSUS | - |
dc.subject | PREDNISONE | - |
dc.subject | REGIMENS | - |
dc.title | Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Y. H. | - |
dc.contributor.affiliatedAuthor | Choi, S. J. | - |
dc.contributor.affiliatedAuthor | Song, G. G. | - |
dc.identifier.doi | 10.1177/0961203309357763 | - |
dc.identifier.scopusid | 2-s2.0-77950204511 | - |
dc.identifier.wosid | 000276856600006 | - |
dc.identifier.bibliographicCitation | LUPUS, v.19, no.6, pp.703 - 710 | - |
dc.relation.isPartOf | LUPUS | - |
dc.citation.title | LUPUS | - |
dc.citation.volume | 19 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 703 | - |
dc.citation.endPage | 710 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | MYCOPHENOLATE-MOFETIL | - |
dc.subject.keywordPlus | INTRAVENOUS CYCLOPHOSPHAMIDE | - |
dc.subject.keywordPlus | IMMUNOSUPPRESSIVE THERAPY | - |
dc.subject.keywordPlus | PULSE CYCLOPHOSPHAMIDE | - |
dc.subject.keywordPlus | LONG-TERM | - |
dc.subject.keywordPlus | AZATHIOPRINE | - |
dc.subject.keywordPlus | ERYTHEMATOSUS | - |
dc.subject.keywordPlus | PREDNISONE | - |
dc.subject.keywordPlus | REGIMENS | - |
dc.subject.keywordAuthor | cyclophosphamide | - |
dc.subject.keywordAuthor | lupus nephritis | - |
dc.subject.keywordAuthor | meta-analysis | - |
dc.subject.keywordAuthor | mycophenolate mofetil | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.